Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect of Interleukin-2 on Active Dermatomyositis: A Multicenter, Randomised, Double-blind, Placebo-controlled Trial

NCT05495321 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05495321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05495321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect of Interleukin-2 on Active Dermatomyositis: A Multicenter, Randomised, Double-blind, Placebo-controlled Trial
Lead sponsor
Peking University People's Hospital
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
December 1, 2022
Completion date
September 1, 2026
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis